(From far left) EndoMaster CEO Goh Seow Ping, non-executive chairman Prof Louis Phee, and COO Colin Tan. The company aims to complete clinical trials of the robotic system by 2Q 2019.
Caption: 
(From far left) EndoMaster CEO Goh Seow Ping, non-executive chairman Prof Louis Phee, and COO Colin Tan. The company aims to complete clinical trials of the robotic system by 2Q 2019.